Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

FDA-Health Canada Regulatory Cooperation Council (RCC) Town Hall

Session Chair(s)

Louise  Déry

Louise Déry

Director, Policy, Planning and International Affairs Directorate

Health Canada, Canada

This forum will discuss and inform stakeholders about the Canada-US Regulatory Cooperation Council (RCC) established by President Obama and Prime Minister Harper in 2012 and the projects the US FDA and Health Products and Food Branch of Health Canada are currently pursuing under this initiative. Presentations will be followed by a question and answer period. An opportunity will be provided to express views and input on current and potential future projects under the RCC.

Learning Objective : Discuss and inform stakeholders about the Canada-US Regulatory Cooperation Council (RCC) established by President Obama and Prime Minister Harper in 2012 and the projects the US FDA and Health Products and Food Branch of Health Canada are currently pursuing under this initiative.

Speaker(s)

Louise  Déry

Panelist

Louise Déry

Health Canada, Canada

Director, Policy, Planning and International Affairs Directorate

Murray M. Lumpkin, DrMed, MD, MSc

Panelist

Murray M. Lumpkin, DrMed, MD, MSc

Bill and Melinda Gates Foundation, United States

Deputy Director, Integrated Development, Lead for Global Reg Systems Initiative

Sema  Hashemi, MSc

Panelist

Sema Hashemi, MSc

FDA, United States

Senior International Policy Advisor, OGPS, OC

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.